HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A slow-cycling subpopulation of melanoma cells with highly invasive properties.

Abstract
Melanoma is a heterogeneous tumor with different subpopulations showing different proliferation rates. Slow-cycling cells were previously identified in melanoma, but not fully biologically characterized. Using the label-retention method, we identified a subpopulation of slow-cycling cells, defined as label-retaining cells (LRC), with strong invasive properties. We demonstrate through live imaging that LRC are leaving the primary tumor mass at a very early stage and disseminate to peripheral organs. Through global proteome analyses, we identified the secreted protein SerpinE2/protease nexin-1 as causative for the highly invasive potential of LRC in melanomas.
AuthorsM Perego, M Maurer, J X Wang, S Shaffer, A C Müller, K Parapatics, L Li, D Hristova, S Shin, F Keeney, S Liu, X Xu, A Raj, J K Jensen, K L Bennett, S N Wagner, R Somasundaram, M Herlyn
JournalOncogene (Oncogene) Vol. 37 Issue 3 Pg. 302-312 (01 18 2018) ISSN: 1476-5594 [Electronic] England
PMID28925403 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • SERPINE2 protein, human
  • Serpin E2
Topics
  • Animals
  • Cell Cycle
  • Cell Line, Tumor
  • Cell Separation (methods)
  • Flow Cytometry (methods)
  • Humans
  • Melanocytes (metabolism, pathology)
  • Melanoma (pathology)
  • Mice
  • Neoplasm Invasiveness (pathology)
  • Proteomics
  • Serpin E2 (metabolism)
  • Skin (cytology, pathology)
  • Skin Neoplasms (pathology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: